International Journal of Head and Neck Surgery

Register      Login

VOLUME 6 , ISSUE 1 ( January-March, 2015 ) > List of Articles

CASE REPORT

Use of Intralesional Bleomycin for Oral Hemangioma of Sturge-Weber Syndrome

Devayani Shinde, Yogesh G Dabholkar, Akanksha A Saberwal, Haritosh Kamalakar Velankar, Adip K Shetty

Citation Information : Shinde D, Dabholkar YG, Saberwal AA, Velankar HK, Shetty AK. Use of Intralesional Bleomycin for Oral Hemangioma of Sturge-Weber Syndrome. Int J Head Neck Surg 2015; 6 (1):17-19.

DOI: 10.5005/jp-journals-10001-1211

Published Online: 00-03-2015

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Shinde D, Dabholkar YG, Saberwal AA, Velankar HK, Shetty AK. Use of Intralesional Bleomycin for Oral Hemangioma of Sturge-Weber Syndrome. Int J Head Neck Surg 2015;6(1):17-19.


PDF Share
  1. Clinical features of Sturge-Weber syndrome. Int Arch Otorhinolaryngol 2008;12(4):565-570.
  2. Sclerotherapy for treatment of hemangiomas. Dermatol Surg 2000;26(2):105-108.
  3. Double-needle sclerotherapy of lymphangiomas and venous angiomas in children: a simple technique to prevent complications. Am J Roentgenol 2003 May;180(5):1399-1401.
  4. Sturge-Weber syndrome without facial nevus. 3. Pediatr Neurol 2000 May; 22(5):400-402.
  5. Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence. Pediatr Surg Int 2013 Jun;29(6):575-578.
  6. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants. J Am Acad Dermatol 2011 Aug;65(2):320-327.
  7. Oral corticosteroid use is effective for cutaneous hemangiomas an evidence-based evaluation. Arch Dermatol 2001;137(9):1208-1221.
  8. Ethanol sclerotherapy reduces pain in symptomatic musculoskeletal hemangiomas. Clin Orthop Relat Res 2009 Nov;467(11):2955-2961.
  9. Lymphangioma: is intralesional bleomycin sclerotherapy effective? Biomed Imaging Interv J 2011 Jul-Sep;7(3):e18.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.